Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasmodium vivax polymorphism in a clinical drug trial.

Clinical and diagnostic laboratory immunology - 1 Sept 2001

Adak T, Valecha N, Sharma V P

Abstract excerpt

Data from a double-blind randomized clinical drug trial were analyzed to find the comparative responses of two antirelapse drugs, bulaquine and primaquine, against different relapsing forms of Plasmodium vivax infection. A 1-year follow-up study strongly suggests that the duration of preerythrocytic development of P. vivax is a polymorphic characteristic, exhibited by two strains of hypnozoites responsible for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Antimalarials
Share to Double-Blind Method

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Drug Resistance

Share to Malaria, Vivax

Share to Plasmodium vivax

Share to Secondary Prevention

Source

Open in PubMed Open full text

Identifiers

PMID: 11527798
DOI: 10.1128/CDLI.8.5.891-894.2001
PMCID: PMC96166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Plasmodium vivax polymorphism in a clinical drug trial.PMID 11527798Read ↗

Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.Semantic proximity Read ↗

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.Semantic proximity Read ↗

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.Semantic proximity Read ↗

The rise and fall of long-latency Plasmodium vivaxSemantic proximity Read ↗

Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers.Semantic proximity Read ↗

Monoamine oxidase-A (MAO-A) low-expression variants and increased risk of Plasmodium vivax malaria relapses.Semantic proximity Read ↗

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.Semantic proximity Read ↗

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.